Cargando…

The Repurposing Drugs in Oncology (ReDO) Project

The Repurposing Drugs in Oncology (ReDO) Project seeks to repurpose well-known and well-characterised non-cancer drugs for new uses in oncology. The rationale for this project is presented, examining current issues in oncological drug development, challenges for health systems, and existing and futu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pantziarka, Pan, Bouche, Gauthier, Meheus, Lydie, Sukhatme, Vidula, Sukhatme, Vikas P., Vikas, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2014
Materias:	Policy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096030/ https://www.ncbi.nlm.nih.gov/pubmed/25075216 http://dx.doi.org/10.3332/ecancer.2014.442

Ejemplares similares

Repurposing Drugs in Oncology (ReDO)—mebendazole as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2014)

Repurposing Drugs in Oncology (ReDO)—itraconazole as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2015)

Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2016)

Repurposing drugs in oncology (ReDO)—cimetidine as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2014)

Repurposing Drugs in Oncology (ReDO)—nitroglycerin as an anti-cancer agent
por: Sukhatme, Vidula, et al.
Publicado: (2015)

Repurposing Drugs in Oncology (ReDO)—Propranolol as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2016)

Repurposing Drugs in Oncology (ReDO)—clarithromycin as an anti-cancer agent
por: Van Nuffel, An MT, et al.
Publicado: (2015)

Repurposing drugs in oncology (ReDO)—selective PDE5 inhibitors as anti-cancer agents
por: Pantziarka, Pan, et al.
Publicado: (2018)

Repurposing Drugs in Oncology (ReDO)—chloroquine and hydroxychloroquine as anti-cancer agents
por: Verbaanderd, Ciska, et al.
Publicado: (2017)

ReDO_DB: the repurposing drugs in oncology database
por: Pantziarka, Pan, et al.
Publicado: (2018)

“Hard” Drug Repurposing for Precision Oncology: The Missing Link?
por: Pantziarka, Pan, et al.
Publicado: (2018)

A Database of Drug Repurposing Clinical Trials in Oncology
por: Pantziarka, Pan, et al.
Publicado: (2021)

Does the oncology community have a rejection bias when it comes to repurposed drugs?
por: Gyawali, Bishal, et al.
Publicado: (2018)

Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19
por: Sukhatme, Vikas P., et al.
Publicado: (2021)

Available drugs and supplements for rapid deployment for treatment of COVID-19
por: Cicka, Danielle, et al.
Publicado: (2021)

Repurposing Infectious Diseases Vaccines Against Cancer
por: Vandeborne, Liese, et al.
Publicado: (2021)

Drug repurposing as a potential source of innovative therapies in cervical cancer
por: Capistrano I., Rica, et al.
Publicado: (2022)

Editorial: Drug Repurposing
por: Pantziarka, Pan, et al.
Publicado: (2019)

Tumor-derived lactate and myeloid-derived suppressor cells: Linking metabolism to cancer immunology
por: Husain, Zaheed, et al.
Publicado: (2013)

Impact of concomitant fibrates on immunotherapy outcomes for advanced non‐small cell lung cancer
por: Stokes, William A., et al.
Publicado: (2022)

Inconsistencies and questionable reliability of the publication “Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophages-activating, GcMAF” by Yamamoto et al
por: Ugarte, Ana, et al.
Publicado: (2014)

Abstract: Adipose-Derived Aldehyde-Dehydrogenase-Expressing Cells Accelerate Re-vascularization of Collagen-Glycosaminoglycan Scaffolds
por: Matsumine, Hajime, et al.
Publicado: (2016)

The wisdom of crowds and the repurposing of artesunate as an anticancer drug
por: Augustin, Yolanda, et al.
Publicado: (2015)

Induction of Erythroid Differentiation in Human Erythroleukemia Cells by Depletion of Malic Enzyme 2
por: Ren, Jian-Guo, et al.
Publicado: (2010)

Repurposing of drugs for triple negative breast cancer: an overview
por: Spini, Andrea, et al.
Publicado: (2020)

A Case of Complete and Durable Molecular Remission of Chronic Lymphocytic Leukemia Following Treatment with Epigallocatechin-3-gallate, an Extract of Green Tea
por: Lemanne, Dawn, et al.
Publicado: (2015)

An Open Access Database of Licensed Cancer Drugs
por: Pantziarka, Pan, et al.
Publicado: (2021)

Drug Repurposing by Tumor Tissue Editing
por: Lüke, Florian, et al.
Publicado: (2022)

On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients
por: Verbaanderd, Ciska, et al.
Publicado: (2020)

High energy pp data and the Reggeon theory of diffraction scattering
por: Sukhatme, U P, et al.
Publicado: (1974)

Teoría de encuestas por muestreo con aplicaciones /
por: Sukhatme, Pandurang Vasudeo, 1911-
Publicado: (1962)

Excess Circulating Angiopoietin-2 May Contribute to Pulmonary Vascular Leak in Sepsis in Humans
por: Parikh, Samir M, et al.
Publicado: (2006)

Citrate Suppresses Tumor Growth in Multiple Models through Inhibition of Glycolysis, the Tricarboxylic Acid Cycle and the IGF-1R Pathway
por: Ren, Jian-Guo, et al.
Publicado: (2017)

Precision oncology in Latin America: current situation, challenges and perspectives
por: Calderón-Aparicio, Ali, et al.
Publicado: (2019)

Best practice in nurse-led chemotherapy review: a position statement from the United Kingdom Oncology Nursing Society
por: Lennan, E, et al.
Publicado: (2012)

Chemotherapy-generated cell debris stimulates colon carcinoma tumor growth via osteopontin
por: Chang, Jaimie, et al.
Publicado: (2019)

International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines
por: de Campos Vieira Abib, Simone, et al.
Publicado: (2022)

Oncology Drug Repurposing for Sepsis Treatment
por: Rumienczyk, Izabela, et al.
Publicado: (2022)

Repurposing Drugs in Small Animal Oncology
por: Giuliano, Antonio, et al.
Publicado: (2022)

The Role of Dopamine in Repurposing Drugs for Oncology
por: Moura, Catarina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sq6hnaskdnjg2hik0s9kae3gqn